COMMON & BRAND NAMES
Atomoxetine is a selective norepinephrine reuptake inhibitor (SNRI) approved as a less stimulating treatment for ADHD in 2002 (U.S.). The precise mechanism by which it produces its therapeutic effects is unknown, but is thought to be related to its SNRI action.
Hardcore Hallucinations, by Mad Trails
Not What I Expected, by GBVsoldier
Antidepressant Soupbowl Hell, by joes moldy bread
Concentration but Not Worth It, by domin8
PRIMARY RESOURCES #